Make A Donation!

Help us cover the cost of running this website and help with the fight against hepatitis C! We appreciate your support!

Magazine - The Hep Factor

The Hep Factor - Thanks to the Hepatitis C Council of Queensland

Web Version | Print Version

Magazine - Hep C Review

The Hep C Review - Thanks to the Hepatitis C Council of NSW

Part 1 | Part 2

Hep C Community News

Hep C Community News - Thanks to the Hepatitis C Council of South Australia

Magazine - Good Liver

Good Liver - Thanks to the Hepatitis C Council of Victoria
Treatment News
   Display # 
# Article Title Date Hits
1 Old drug may hold promise against hepatitis C Monday, 01 September 2008 33
2 Phase 3 'REALIZE' Trial with Telaprevir in Treatment-Failure HCV Patients Wednesday, 20 August 2008 74
3 Patient trial for wonder drug FT-11 Monday, 18 August 2008 103
4 NZ-made flu drug promises many uses Saturday, 16 August 2008 91
5 Biotron expands HCV trial Thursday, 14 August 2008 75
6 Immune paradox could help treat Aids - Hepatitis C Thursday, 14 August 2008 65
7 New studies examine use of the nucleoside polymerase inhibitor, R1626 Monday, 11 August 2008 53
8 Genes might be key to hepatitis C Sunday, 10 August 2008 118
9 Early Treatment Is Key To Combating Hepatitis C Virus Saturday, 09 August 2008 127
10 R1626 Could Help Defeat Hepatitis C Saturday, 09 August 2008 56
11 Vertex falls on data for Schering hepatitis drug Tuesday, 05 August 2008 136
12 Results of Boceprevir Phase II Study Tuesday, 05 August 2008 108
13 New treatment therapy helps inhibit hepatitis C Friday, 01 August 2008 120
14 Study: Hepatitis C does not impede HIV treatment Friday, 25 July 2008 93
15 Improved culture system for hepatitis C virus infection Friday, 18 July 2008 109
16 A New Drug Therapy Study Thursday, 17 July 2008 114
17 Steroid-Free Immunosuppression Without Induction Is Safe and Effective After Liver Transplant Tuesday, 15 July 2008 91
18 Liver lifeline - Sorafenib Monday, 14 July 2008 165
19 Hepatitis C Virus May Need Enzyme's Help To Cause Liver Disease Thursday, 10 July 2008 123
20 Giaconda Suspends Hepaconda Phase II Trial to Carry Out Dose Ranging Wednesday, 09 July 2008 92
21 Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV Tuesday, 08 July 2008 105
22 Peptide Vaccine Shows Some Promise in Hard-To-Treat HCV Wednesday, 02 July 2008 180
23 Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Tuesday, 01 July 2008 155
24 New Technology May Help Treat Hepatitis Tuesday, 01 July 2008 177
25 Good News for Non-Responders to HCV Combination Therapy Tuesday, 01 July 2008 209
26 European Commission Approves Shortened Treatment With Peginterferon Alfa-2a Plus Ribavirin for Specific Hepatitis C Patients Saturday, 28 June 2008 151
27 UPDATE 1-EU clears shorter course of Roche hepatitis C drug Saturday, 28 June 2008 139
28 Vertex Investors Balk at New Study Plans Wednesday, 25 June 2008 107
29 Novel Agents Will Drive The Hepatitis C Virus Drug Market to Increase Nearly Five-Fold to More than $10 Billion in 2017 Friday, 20 June 2008 125
30 Vertex CEO preparing for '09 hepatitis drug launch Friday, 20 June 2008 187
31 Vertex Unveils More Upbeat Hep C Drug Data Tuesday, 17 June 2008 165
32 Longer Treatment Recommended for Genotype 6 Tuesday, 17 June 2008 135
33 New Breakthrough Could Prevent Hepatitis C Replication Tuesday, 17 June 2008 189
34 HCV Viral Load Reduced in Phase I/II Trial Tuesday, 17 June 2008 124
35 HCV Treatment Success: Early Response vs. Genotype Tuesday, 17 June 2008 154
36 Valeant says hepatitis C drug causes less anemia Saturday, 14 June 2008 176
37 Vertex Reports 52% SVR 12 Rate for a 24-week Telaprevir-based Regimen in Genotype 1 Hepatitis C Patients Who Failed Prior Treatment Tuesday, 10 June 2008 186
38 Antipodean Pharmaceuticals Announces FDA Acceptance of IND for MitoQ(R) Thursday, 05 June 2008 145
39 Biochips Fighting Viruses Wednesday, 04 June 2008 132
40 Twelve-Week Protease-Based Triple Therapy Results in High HCV Cure Rates Thursday, 29 May 2008 304
41 Santaris Pharma Begins Human Clinical Testing of the World’s First Medicine Targeted at a Human microRNA Thursday, 29 May 2008 195
42 Boehringer unveils Laval research investment Wednesday, 28 May 2008 175
43 Overcoming virus early beats hepatitis Sunday, 25 May 2008 135
44 Galectin-3 Test May Reduce Unnecessary Thyroid Surgeries Saturday, 24 May 2008 182
45 Therapeutic vaccine TG4040 (MVA-HCV) Tuesday, 20 May 2008 180
46 Fluvastatin May Lower Viral Load for Hepatitis C Patients Saturday, 17 May 2008 170
47 Sulfasalazine’s Potential for Reversing Fibrosis Friday, 16 May 2008 278
48 Improves Outcome for Hep C Genotype 4 Saturday, 10 May 2008 160
49 Positive Findings in Treatment for Advanced Hepatitis C Thursday, 08 May 2008 177
50 Can-Fite Successfully Completed Phase I Clinical Trial with its 2nd Drug CF102 Wednesday, 07 May 2008 156
51 Grapefruit May Curb Hepatitis C Sunday, 04 May 2008 208
52 Boceprevir Active, Well-Tolerated in Treatment-Naive Patients With HCV-1: Presented at EASL Thursday, 01 May 2008 188
53 Roche presents favorable data on hepatitis drug Pegasys Wednesday, 30 April 2008 195
54 Clinical Update - Debio 025 in Hepatitis C Wednesday, 30 April 2008 183
55 New drug could transform the treatment of hepatitis C Tuesday, 29 April 2008 170
56 Pharmasset expands cohorts in Phase I hepatitis C study Tuesday, 29 April 2008 184
57 Hepatitis C Polymerase Inhibitor, R1626, Demonstrated Significant End-of-Treatment Response in Phase IIa Study Tuesday, 29 April 2008 186
58 Hepatitis C therapy peginterferon alfa-2b shows promise Monday, 28 April 2008 156
59 Telaprevir-Based PROVE Studies Show Significantly Higher SVR Rates in Treatment-Naive Genotype 1 Hepatitis C Patients in Half the Time of Current Treatments Thursday, 24 April 2008 229
60 Vertex Pharmaceuticals Reviews Clinical Advancements and Reports First Quarter 2008 Financial Results Tuesday, 22 April 2008 203
61 HEPATITIS C - MANAGING THE SIDE EFFECTS Tuesday, 22 April 2008 308
62 Common side effects of hepatitis C treatment Tuesday, 22 April 2008 367
63 Treatment with sunitinib slows tumor growth and spread of liver cancer Monday, 21 April 2008 200
64 Romark Laboratories launches hepatitis C trial Monday, 21 April 2008 197
65 HCV Drug Could Be A Winner Monday, 21 April 2008 188
66 Schering-Plough To Present Data On Chronic Hepatitis C Therapies Monday, 21 April 2008 187
67 ViroPharma ends development of hepatitis C drug Sunday, 20 April 2008 175
68 Hepatitis C : Identification Of A Protein That Inhibits The Virus Wednesday, 16 April 2008 193
69 Roche anti-HCV assay use expanded Tuesday, 15 April 2008 214
70 FDA Approvals: Rotarix and PegIntron/Rebetol Saturday, 12 April 2008 186
71 Anti-cholesterol medicine could help fight hepatitis C Saturday, 12 April 2008 192
72 Studies suggest statins fight it Saturday, 12 April 2008 184
73 A Drug's Ability To Achieve Sustained Viral Response in Genotype 1 Thursday, 10 April 2008 174
74 Pegylated Interferon Alpha-2a Advantageous in Dialysis Patients With Hepatitis C Tuesday, 08 April 2008 216
75 New drug offers hope in treating hepatitis C Tuesday, 08 April 2008 183
76 New Method Disrupts Hepatitis C Virion Production Sunday, 23 March 2008 190
77 Scripps Florida Scientists Develop a Process to Disrupt Hepatitis C Saturday, 22 March 2008 190
78 How to defeat a virus Saturday, 22 March 2008 207
79 Sulfasalazine’s Potential for Reversing Fibrosis Saturday, 22 March 2008 229
80 GI-5005 for chronic hepatitis C infection Thursday, 20 March 2008 230
81 Peginterferon-Ribavirin Safe, Effective for Children With HCV Wednesday, 19 March 2008 201
82 Valeant: “Encouraging” Drug Trial Results Tuesday, 18 March 2008 212
83 Agreement to Bring Rapid, Oral HCV Test Outside the U.S. Friday, 07 March 2008 223
84 Treatment of Hepatitis C Thursday, 06 March 2008 200
85 Serum fibrosis markers correlate with liver fibrosis stage Wednesday, 05 March 2008 227
86 Albuferon Saturday, 01 March 2008 175
87 Trial to test radiation-emitting beads against advanced liver cancer Wednesday, 27 February 2008 203
88 Will STAT-C Replace Today's HCV Standard Therapy? Wednesday, 27 February 2008 207
89 Amarillo granted FDA approval for Phase II hepatitis C trial Monday, 25 February 2008 178
90 Pafuramidine Sunday, 24 February 2008 190
91 Hepatitis C Trial Sunday, 17 February 2008 203
92 Exploring Differences in Response to Treatment Geno 2 & 3 Saturday, 16 February 2008 216
93 Phase 2a Trial of Locteron® in Hepatitis C Tuesday, 12 February 2008 210
94 Hepatitis C Treatments in Current Clinical Development Sunday, 03 February 2008 304
95 Adjustment of Treatment Duration Based on Early Response Sunday, 03 February 2008 192
96 IDEAL Trial Results Sunday, 03 February 2008 185
97 SVR and Disease Progression Sunday, 03 February 2008 166
98 An Updated Report on Hepatitis C Genotypes Tuesday, 29 January 2008 246
99 Human Genome Sciences shares fall on hepatitis C drug results Monday, 28 January 2008 186
100 Telaprevir, Investigational Hepatitis C Protease Inhibitor Thursday, 24 January 2008 289
101 CB2 receptors as new therapeutic targets for liver diseases Tuesday, 22 January 2008 165
102 FDA Receives New Data on Risks of Anemia Drugs Monday, 21 January 2008 256
103 Treatment of Hepatitis C Reduces Incidence of Non-Hodgkin’s Lymphoma Saturday, 19 January 2008 243
104 Alinia - Drug's promise revitalizes firm Monday, 07 January 2008 304
105 Hepatitis C: Less Treatment OK for Some Saturday, 05 January 2008 267
106 Fibrosis can be Stopped, Cured and Reversed Thursday, 03 January 2008 301
107 New Blood Test Offers Hope For Biopsy-Free Treatment Saturday, 29 December 2007 249
108 Weight-Based Dosing Is Key to Optimal Treatment Saturday, 29 December 2007 259
109 Research Into New Drugs to Treat HCV Thursday, 20 December 2007 299
110 Oglufanide Thursday, 20 December 2007 239
111 Antibody Isolation May Prevent or Slow HCV Tuesday, 18 December 2007 259
112 Celgosivir (MX-3253) Sunday, 09 December 2007 181
113 Treatment could slow hep C Saturday, 08 December 2007 298
114 Scientists one step closer to Hep C vaccine Saturday, 08 December 2007 291
115 Phlebotomy Gaining Acceptance as HCV Treatment Wednesday, 05 December 2007 350
116 Drugs in Development Sunday, 02 December 2007 202
117 Hepatitis C Treatments in Current Clinical Development Sunday, 02 December 2007 467
118 Drug 'benefits hep C patients' Saturday, 01 December 2007 271
119 Unsafe, Misrepresented Drugs Purchased Over the Internet Wednesday, 28 November 2007 167
120 Aranesp (darbepoetin alfa), Epogen (epoetin alfa), Procrit (epoetin alfa) Wednesday, 28 November 2007 286
121 Hepatitis C drug candidate successful Tuesday, 27 November 2007 261
122 New treatment for chronic hepatitis C leads to less side effects Saturday, 24 November 2007 255
123 Weight-Based Ribavirin Saturday, 24 November 2007 235
124 Study: Gene mutations block hepatitis C therapy Friday, 23 November 2007 264
125 Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression Wednesday, 21 November 2007 254
126 16 New Treatments For Hepatitis C. Tuesday, 20 November 2007 3069
127 First and Only Peginterferon Therapy Approved for Retreating Relapsers & Non-responders Tuesday, 20 November 2007 271
128 Hepatitis C treatment reduces the virus but serious liver problems may progress Monday, 19 November 2007 218
129 Survival In Hepatitis C Virus Patients Prolonged By 24-Week Course Of Interferon-Alpha Therapy Monday, 19 November 2007 178
130 HGS announces results of Phase 2B trial of Albuferon for chronic hepatitis C Monday, 19 November 2007 237
131 New York State Department of Health (NYSDOH) Stops a World First U.S. - Egyptian Collaborative Study Monday, 19 November 2007 237
132 Retreating Hepatitis C Patients Who Failed Previous Therapy Friday, 16 November 2007 246
133 Geno 3-increased doses, longer treatment. Thursday, 15 November 2007 211
134 Acute Hepatitis C In A Contemporary US Cohort Thursday, 15 November 2007 186
135 Trials Of Promacta®/Revolade™ (eltrombopag) Thursday, 15 November 2007 210
136 Drugs in Development-results Sunday, 11 November 2007 174
137 Consensus Interferon in Hepatitis C Saturday, 10 November 2007 268
138 Hepatitis C virus found to spread directly from cell to cell by-passing antibodies Wednesday, 07 November 2007 209
139 Treating HCV Patients with Psychiatric Disorders Wednesday, 07 November 2007 243
140 Recent Findings Present New Strategy to Fight Hepatitis C Wednesday, 07 November 2007 237
141 Combination chemotherapy and hepatocellular carcinoma Thursday, 25 October 2007 282
142 New Antiviral Mechanism Tuesday, 23 October 2007 266
143 Locteron Tuesday, 23 October 2007 254
144 Boceprevir Saturday, 20 October 2007 211
145 Viral Clearance Several Months after Discontinuation of Therapy Saturday, 20 October 2007 198
146 New discovery for hepatitis C Saturday, 20 October 2007 279
147 Hepatitis C Vaccine Ready for Phase I Trial Friday, 19 October 2007 313
148 Delisheng shows anti-cancer effects on hepatocellular carcinoma Wednesday, 17 October 2007 301
149 Self-Recovery from Hepatitis C Sunday, 07 October 2007 320
150 Hep C Treatment Experiences Sunday, 07 October 2007 210
151 New Therapeutic Vaccine Wednesday, 03 October 2007 224
152 New approach to liver failure Tuesday, 02 October 2007 298
153 Hepatitis C Support Groups in the USA Friday, 28 September 2007 250
154 Phase 1b Trial of ITMN-191 Thursday, 27 September 2007 245
155 Alinia Wednesday, 26 September 2007 226
156 Research from Metabasis Therapeutics, Friday, 21 September 2007 190
157 Sorafenib (Nexavar) & Hepatitis C Monday, 17 September 2007 313
158 Support in New Zealand Friday, 14 September 2007 181
159 Virus experts step closer Friday, 14 September 2007 254
160 Hepatitis C drug meets trial goals Friday, 14 September 2007 1018
161 Alinia Tablets and Hepatitis C Wednesday, 12 September 2007 270
162 Sustained Response to Antiviral Treatment Sunday, 09 September 2007 234
163 Hep C hope hovers on the horizon Sunday, 09 September 2007 208
164 Nexavar - Liver Cancer Tuesday, 04 September 2007 293
165 Hepatitis C Virus Vaccine Tuesday, 04 September 2007 248
166 Research looks at hepatitis C recovery Tuesday, 04 September 2007 264
167 Albuferon-Interim Results-Phase II Thursday, 30 August 2007 214
168 Albuferon Thursday, 30 August 2007 203
169 3-Drug HCV therapy for 12 weeks Thursday, 30 August 2007 303
170 A Study of HCV Polymerase Inhibitor Pro-Drug Friday, 24 August 2007 239
171 New Technology and Methods to Fight Hepatitis C Friday, 10 August 2007 293
172 Vertex shares leap on hepatitis C drug data Friday, 27 July 2007 219
173 Treatment of Chronic Hepatitis C in Older Patients Friday, 27 July 2007 254
174 Shortened Hepatitis C Treatment Increases Relapse Rate Friday, 20 July 2007 234
175 Medical Marijuana with Hepatitis C Friday, 06 July 2007 442
176 Interferon Treatment For Hepatitis C Friday, 06 July 2007 385
177 Treatment Experiences Wednesday, 27 June 2007 260
178 Sustained Virological Response in Prior Relapsers Friday, 22 June 2007 245
179 New Targets for Anti-HCV Therapy Saturday, 16 June 2007 251
180 Adherence to HCV Therapy Saturday, 16 June 2007 251
181 Clinical Trials Wednesday, 06 June 2007 243
182 Statins Improve Sustained Response to Interferon-based Therapy in Small Study Sunday, 03 June 2007 261
183 Statins Active against HCV, Especially When Combined with Interferon Sunday, 03 June 2007 252
184 Study Suggests Cure for Hepatitis C Saturday, 26 May 2007 287
185 New HCV Preferred Treatment Wednesday, 23 May 2007 245
186 Replicative Homeostasis III: implications for antiviral therapy and mechanisms of responses Monday, 14 May 2007 284
187 Can New Protein Lead to New Hepatitis C Medications? Wednesday, 02 May 2007 281
188 HCV Genotype and Disease Progression Thursday, 26 April 2007 301
189 New Drug Helps Hepatitis C Patients Start Antiviral Therapy Tuesday, 13 March 2007 554
190 Oglufanide Tested as Potential Hepatitis C Treatment Thursday, 30 November 2006 224
 

Site, Article & Information Disclaimer

All information and articles provided on our website and forums are to be used as a guideline only. For your own safety, please always consult with a doctor or specialist before making any decisions regarding your health care. By visiting this website you instantly adhere to this policy.